Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
2 studies found for:    HuMax®-TF-ADC | Open Studies
Show Display Options
Rank Status Study
1 Recruiting Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors
Conditions: Ovary Cancer;   Cervix Cancer;   Endometrium Cancer;   Bladder Cancer;   Prostate Cancer (CRPC);   Esophagus Cancer;   Lung Cancer(NSCLC);   Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Intervention: Drug: Tisotumab Vedotin (HuMax-TF-ADC)
2 Recruiting Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors
Conditions: Ovary Cancer;   Cervix Cancer;   Endometrium Cancer;   Bladder Cancer;   Prostate Cancer (CRPC);   Esophagus Cancer;   Lung Cancer (NSCLC)
Intervention: Drug: Tisotumab vedotin (HuMax-TF-ADC)

Study has passed its completion date and status has not been verified in more than two years.